Home>Topics>>Baxter's Earnings Call Reveals Good News For Halozyme
Baxter's Earnings Call Reveals Good News For Halozyme
Long Investing Ideas from Seeking Alpha
Thu, 24 Jan 2013
By PropThink : By Jake King Baxter International ( BAX ) reported financial results for the fourth quarter and full-year 2012, and in a conference call following the press release, expressed confidence that HyQvia, a subcuta neous (( SC)) ver sion of Baxter's blockbuster Gammagard product, is up ...